Clinical Trial Update: Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chidamide in combination with cladribine for refractory/relapsed acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Chidamide (chidamide)
• Cladribine (cladribine)

Snippet

Sponsor: Ge Zheng | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN